Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients

Authors

  • Abdorreza Naser Moghadasi Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran

DOI:

https://doi.org/10.18502/ijph.v50i7.6654

Abstract

The article’s abstract is not available.

Downloads

Published

2021-07-05

Issue

Volume (50) issue (7)

Section

Articles